On February 27, 2025, Lelio Marmora, a Director at OraSure Technologies Inc, purchased 7,000 shares of the company, as reported in a SEC Filing. Following this transaction, the insider now holds a total of 67,720 shares in the company. OraSure Technologies Inc (OSUR, Financial) is a company that specializes in the development, manufacture, and distribution of oral fluid diagnostic and collection devices. The company provides products for the detection of various medical conditions and diseases, including infectious diseases and substance abuse. The recent purchase by Lelio Marmora marks the only insider buy within the past year, with no insider sells recorded during the same period. This transaction aligns with the insider's trading history over the past year, which shows a total purchase of 7,000 shares and no sales. On the day of the purchase, shares of OraSure Technologies Inc were trading at $3.06 each, resulting in a market cap of $233.481 million. The stock's GF Value was estimated at $2.74, giving it a price-to-GF-Value ratio of 1.12. This indicates that the stock is modestly overvalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using historical multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company’s past returns and growth, along with future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
